KATHERINE LAMPERT: Open Payments
NPI 1932552262 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,422 in 223 payments from 18 companies in 2025. Trend: 2023 $3,344 · 2024 $5,737 · 2025 $4,422
Food & beverage: $4,255Education: $167
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 87 | $1,568 |
| Janssen Biotech, Inc. | 23 | $658 |
| Novartis Pharmaceuticals Corporation | 34 | $515 |
| UCB, Inc. | 15 | $321 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 12 | $289 |
| Incyte Corporation | 9 | $174 |
| GENZYME CORPORATION | 9 | $160 |
| Regeneron Healthcare Solutions, Inc. | 7 | $158 |
| Lilly USA, LLC | 6 | $114 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $109 |
Products named: SKYRIZI, TREMFYA, RINVOQ, COSENTYX, DUPIXENT, Bimzelx, OPZELURA, SILIQ.
Industry payments across NY — which companies pay providers there.
